1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone
C44H49Cl3F6N8O5 — CID 159943861
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone
1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone (PubChem CID 159943861) has the molecular formula C44H49Cl3F6N8O5 and a molecular weight of 990.27 g/mol. Its IUPAC name is 1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone.
Molecular Properties
| Compound Name | 1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone |
|---|---|
| PubChem CID | 159943861 |
| Molecular Formula | C44H49Cl3F6N8O5 |
| Molecular Weight | 990.27 g/mol |
| Exact Mass | 988.28 |
| IUPAC Name | 1-[2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-(4-chlorophenyl)piperidine-4-carboxylic acid;1-[4-(4-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]-2-[4,5-dimethyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone |
| SMILES | Cc1c(C(F)(F)F)nn(CC(=O)N2CCC(C(=O)N3CCN(C)CC3)(c3ccc(Cl)cc3)CC2)c1C.Cc1c(Cl)c(C(F)(F)F)nn1CC(=O)N1CCC(C(=O)O)(c2ccc(Cl)cc2)CC1 |
| InChI | InChI=1S/C25H31ClF3N5O2.C19H18Cl2F3N3O3/c1-17-18(2)34(30-22(17)25(27,28)29)16-21(35)32-10-8-24(9-11-32,19-4-6-20(26)7-5-19)23(36)33-14-12-31(3)13-15-33;1-11-15(21)16(19(22,23)24)25-27(11)10-14(28)26-8-6-18(7-9-26,17(29)30)12-2-4-13(20)5-3-12/h4-7H,8-16H2,1-3H3;2-5H,6-10H2,1H3,(H,29,30) |
| InChIKey | OBFSFMIIDAXLMB-UHFFFAOYSA-N |
| XLogP | 7.67 |
| TPSA | 137.11 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 990.27 |
| LogP ≤ 5 | 7.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159943861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.